Powerful CRISPR-Based Biosensing Techniques and Their Integration With Microfluidic Platforms.

Area of Science:

• Biotechnology
• Molecular Diagnostics
• Biosensing

Background:

• Polymerase chain reaction (PCR) is a sensitive nucleic acid detection method but requires thermal cycling, expensive equipment, and trained personnel.
• Limitations of PCR include long turnaround times and the need for specialized laboratory settings.
• There is an urgent need for simple, rapid, and sensitive diagnostic tools, especially for pandemics like COVID-19.

Purpose of the Study:

• To review recent advancements in clustered regularly interspaced short palindromic repeats (CRISPR)-based biosensing techniques.
• To explore the integration of CRISPR biosensors with microfluidic platforms for enhanced diagnostics.
• To discuss the potential applications and future challenges of these combined technologies.

Main Methods:

• Review of current literature on CRISPR-based biosensors for nucleic acid detection.
• Analysis of microfluidic chip integration for sample processing and analysis.
• Discussion of signal amplification strategies to improve specificity and efficiency.

Main Results:

• CRISPR-based biosensors can detect nucleic acids at physiological temperatures, enabling point-of-care applications.
• Microfluidic platforms offer integrated sample processing and analysis, reducing reagent consumption and increasing throughput.
• The combination of CRISPR and microfluidics presents a powerful approach for rapid and sensitive molecular diagnostics.

Conclusions:

• CRISPR-based biosensing integrated with microfluidics shows significant promise for developing advanced point-of-care diagnostic devices.
• Further research is needed to optimize specificity and signal amplification for broader applications.
• These technologies have potential applications in healthcare, animal husbandry, agriculture, and forestry.